Abstract:BackgroundAarskog-Scott syndrome, a rare X-linked genetic disorder, is identified by combined clinical manifestations of short stature, facial, skeletal, and genital anomalies. Annually, two or three new cases are diagnosed with Aarskog-Scott syndrome, which is associated with FGD1 variants. However, there is no specific treatment for Aarskog-Scott syndrome due to its unclear mechanism. MethodsClinical data were collected when the patient first visited the hospital. Trio whole-exome sequencing and Sanger sequencing were performed for the genetic cause of disease. To evaluate the pathogenicity of the variants in vitro, stable cell lines were constructed using lentivirus infection in 143B cell. Furthermore, Western blot was used to verify the expression of signaling pathway-related proteins, and the transcription levels of osteogenic-related genes were verified by luciferase reporter gene assay. ResultsA 7-year-old boy was manifested with facial abnormalities, intellectual disability, and short stature (-3.98 SDS) while the growth hormone level of stimulation test was normal. Trio whole-exome sequencing and Sanger sequencing identified a variant (c.1270A>G, p.Asn424Asp) in FGD1 gene. The Asn424 residue was highly conserved and the hydrogen bond in the FGD1 variant protein has changed, which led to decrease in the interaction with CDC42 protein. In vitro study showed that the Asn424Asp variant significantly decreased the transcription levels of OCN, COL1A1, and ALP activity, and it activated the phosphorylation of JNK1. ConclusionMolecular biological mechanisms between abnormal expression of FGD1and Aarskog-Scott syndrome remain poorly understood. In our study, c.1270A>G variant of FGD1 resulted in Aarskog-Scott syndrome, and the analysis of pathogenicity supports the deleterious effect of the variant. Furthermore, we demonstrated the weakened affinity of the mutant FGD1 and CDC42. Decreased expression of osteogenic-related gene and abnormal activation of JNK1 were also shown in this work.

A Pro253Arg Mutation in Fibroblast Growth Factor Receptor 2 (fgfr2) Causes Skeleton Malformation Mimicking Human Apert Syndrome by Affecting Both Chondrogenesis and Osteogenesis

A Ser250Trp substitution in mouse fibroblast growth factor receptor 2 (Fgfr2) results in craniosynostosis

A Ser252Trp [corrected] substitution in mouse fibroblast growth factor receptor 2 (Fgfr2) results in craniosynostosis.

A Pro250arg Substitution in Mouse Fgfr1 Causes Increased Expression of Cbfa1 and Premature Fusion of Calvarial Sutures

Soluble Form of FGFR2 with S252W Partially Prevents Craniosynostosis of the Apert Mouse Model

A Novel FGFR2 (S137W) Mutation Resulting in Apert Syndrome

Prenatal Diagnosis of Apert Syndrome Due to A De Novo FGFR2 Mutation at the Second Trimester: a Case Report

Gly369Cys Mutation in Mouse FGFR3 Causes Achondroplasia by Affecting Both Chondrogenesis and Osteogenesis.

Therapeutic effect of nanogel-based delivery of soluble FGFR2 with S252W mutation on craniosynostosis

A Lys644Glu Substitution in Fibroblast Growth Factor Receptor 3 (FGFR3) Causes Dwarfism in Mice by Activation of STATs and Ink4 Cell Cycle Inhibitors.

Adeno-Associated Virus-Mediated RNAi against Mutant Alleles Attenuates Abnormal Calvarial Phenotypes in an Apert Syndrome Mouse Model

The Primary Site of the Acrocephalic Feature in Apert Syndrome is a Dwarf Cranial Base with Accelerated Chondrocytic Differentiation Due to Aberrant Activation of the FGFR2 Signaling

RNA Interference and Inhibition of MEK-ERK Signaling Prevent Abnormal Skeletal Phenotypes in a Mouse Model of Craniosynostosis.

Inducible Activation of FGFR2 in Adult Mice Promotes Bone Formation After Bone Marrow Ablation

A Ser(365)-->Cys Mutation of Fibroblast Growth Factor Receptor 3 in Mouse Downregulates Ihh/PTHrP Signals and Causes Severe Achondroplasia.

[Gly374arg Mutation in Fgfr3 Causes Achondroplasia in Mice].

S267P Mutation in FGFR2

Differences in the Clinical Phenotypes of Apert Syndrome with the FGFR2 Mutation Site Ser252Trp and Pro253Arg: Based on Meta Analysis

FGD1 Variant Associated with Aarskog–Scott Syndrome

A Neonatal Lethal Mutation in FGFR3 Uncouples Proliferation and Differentiation of Growth Plate Chondrocytes in Embryos.

Effects of FGFR Signaling on Cell Proliferation and Differentiation of Apert Dental Cells